Peptides
CJC-1295 is one of the most widely studied growth hormone-releasing hormone (GHRH) analogs in peptide research. Whether you're investigating its role in body composition, recovery, sleep quality, or aging, this guide covers everything the science currently supports — including how it compares between the DAC and no-DAC variants and
GLP-1
Tirzepatide has quickly become one of the most talked-about medications in metabolic health — and for good reason. Whether you know it as Mounjaro (for type 2 diabetes) or Zepbound (for weight management), this dual-action molecule is rewriting what we thought was possible with pharmaceutical weight loss. Patients are losing 20%
Peptides
If you've researched peptide therapies for anti-aging, body composition, or recovery, you've almost certainly encountered the name ipamorelin. It consistently ranks as one of the most popular growth hormone secretagogues (GHS) in clinical wellness settings — and for good reason. Ipamorelin delivers a clean, selective burst of
GLP-1
Peptides
VIP (Vasoactive Intestinal Peptide) is the most biologically versatile peptide in the human body — and one of the most underrecognized in clinical practice. Here's what the evidence actually shows.
Peptides
PT-141 works in the brain to create sexual desire — not in the genitals like Viagra. Here's the complete 2026 clinical guide to bremelanotide.
Peptides
Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. With the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), it was engineered as a stable analog of the endogenous immunomodulatory peptide tuftsin. Since its development in the 1990s, Selank has been registered in Russia
Peptides
GHRP-6 is one of the original growth hormone secretagogues — a ghrelin mimetic with potent GH-releasing and cytoprotective properties. Here's everything you need to know in 2026.
Peptides
BPC-157 is one of the most extensively studied healing peptides in preclinical research. Originally derived from human gastric juice, this synthetic 15-amino-acid compound has demonstrated remarkable tissue repair properties across dozens of animal studies — from tendons and ligaments to gut lining and neural tissue. Here's everything you need
GLP-1
Liraglutide has been reshaping metabolic medicine since its FDA approval in 2010. Sold under the brand names Victoza (for type 2 diabetes) and Saxenda (for chronic weight management), it was the first once-daily GLP-1 receptor agonist to demonstrate cardiovascular mortality benefits in a large outcomes trial. Now, in 2026, generic